Paul Tudor Jones Vanda Pharmaceuticals Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 139,040 shares of VNDA stock, worth $785,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,040
Previous 36,412
281.85%
Holding current value
$785,576
Previous $153,000
273.2%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding VNDA
# of Institutions
147Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$46 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$24.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$19.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$13.4 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$10.2 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $320M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...